Red Tree Management, LLC
Red Tree Management, LLC reported 3 US-listed holdings worth $116.7 million in its 13F for the quarter ended 30 September 2026, filed 15 October 2026. Its largest: Bicara Therapeutics Inc. (46.6%), Ceribell Inc. (46.1%) and Contineum Therapeutics Inc. (7.3%). Against the quarter before, it opened 0 positions, added to 0, trimmed 1 and sold out of 0.
The 3 largest of its 3 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q2 2026.
What the fund reported holding at each quarter's end; hover a bar for the number of positions
What its reported holdings returned
Held through each quarter, the holdings it reported returned -11.4% over the 7 quarters to 30 September 2026, against +30.1% for the S&P 500.
Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.
What it did on the quarter
Its positions against its 13F for the quarter to 30 June 2026; a change under 0.1% of a position counts as held
Trimmed 1
- Bicara Therapeutics Inc. BCAX-243,008 shares · -8%
What it holds
| Company | Shares | Value | Of its book | Change in shares |
|---|---|---|---|---|
| Bicara Therapeutics Inc. BCAX | 2.9M | $54.4 million | 46.57% | -243.0K |
| Ceribell Inc. CBLL | 2.2M | $53.8 million | 46.09% | no change |
| Contineum Therapeutics Inc. CTNM | 638.2K | $8.6 million | 7.34% | no change |